Literature DB >> 27670243

T-bet inhibits innate lymphoid cell-mediated eosinophilic airway inflammation by suppressing IL-9 production.

Ayako Matsuki1, Hiroaki Takatori2, Sohei Makita1, Masaya Yokota1, Tomohiro Tamachi1, Akira Suto1, Kotaro Suzuki1, Koichi Hirose1, Hiroshi Nakajima3.   

Abstract

BACKGROUND: Innate lymphoid cells (ILCs) are emerging subsets of immune cells that produce large amounts of cytokines upon cytokine and/or alarmin stimulation. Recent studies have shown that T-bet plays pivotal roles in the development of ILC3s and type 1 ILCs; however, the roles of T-bet in lung type 2 innate lymphoid cells (ILC2s) remain unknown.
OBJECTIVE: We sought to determine the role of T-bet in ILC2-mediated airway inflammation.
METHODS: The expression of T-bet in lung ILCs (defined as Thy1.2+ Lin- cells) was examined. The roles of T-bet in the development of lung ILC2s and airway inflammation induced by IL-33 administration were examined by using T-bet-deficient (T-bet-/-) mice. Gene expression profiles of T-bet-/- lung ILCs were analyzed by RNA sequencing.
RESULTS: T-bet was expressed in lung ILC2s (defined as Thy1.2+ Lin- cells expressing ST2 or CD25) and IFN-γ enhanced its expression. Although the development of lung ILC2s at steady-state conditions was normal in T-bet-/- mice, IL-33-induced accumulation of lung ILC2s and eosinophilic airway inflammation were exacerbated in T-bet-/- mice. The exacerbated accumulation of ILC2s and eosinophilic airway inflammation by the absence of T-bet were evident even in a RAG2-/- background, suggesting that T-bet expressed in non-T/non-B population is involved in the suppression of IL-33-induced eosinophilic airway inflammation. Transcriptome analysis revealed that IL-9 expression in IL-33-stimulated lung ILCs was upregulated in T-bet-/- mice compared with that in wild-type mice. Importantly, neutralization of IL-9 markedly attenuated IL-33-induced accumulation of lung ILC2s and eosinophilic inflammation in T-bet-/- mice.
CONCLUSIONS: T-bet suppresses IL-9 production from lung ILC2s and thereby inhibits IL-33-induced eosinophilic airway inflammation.
Copyright © 2016 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IL-9; T-bet; eosinophils; innate lymphoid cells

Mesh:

Substances:

Year:  2016        PMID: 27670243     DOI: 10.1016/j.jaci.2016.08.022

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  7 in total

Review 1.  Innate Lymphoid Cells (ILCs): Cytokine Hubs Regulating Immunity and Tissue Homeostasis.

Authors:  Maho Nagasawa; Hergen Spits; Xavier Romero Ros
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-12-03       Impact factor: 10.005

Review 2.  Type two innate lymphoid cells: the Janus cells in health and disease.

Authors:  Hadi Maazi; Omid Akbari
Journal:  Immunol Rev       Date:  2017-07       Impact factor: 12.988

Review 3.  Programmed T cell differentiation: Implications for transplantation.

Authors:  Rebecca L Crepeau; Mandy L Ford
Journal:  Cell Immunol       Date:  2020-03-29       Impact factor: 4.868

Review 4.  The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases.

Authors:  Brad Griesenauer; Sophie Paczesny
Journal:  Front Immunol       Date:  2017-04-24       Impact factor: 7.561

Review 5.  Regulatory Mechanisms of IL-33-ST2-Mediated Allergic Inflammation.

Authors:  Hiroaki Takatori; Sohei Makita; Takashi Ito; Ayako Matsuki; Hiroshi Nakajima
Journal:  Front Immunol       Date:  2018-09-04       Impact factor: 7.561

6.  A crosstalk between type 2 innate lymphoid cells and alternative macrophages in lung development and lung diseases (Review).

Authors:  Lan-Lan Mi; Yue Zhu; Hong-Yan Lu
Journal:  Mol Med Rep       Date:  2021-03-31       Impact factor: 2.952

7.  High Th2 cytokine levels and upper airway inflammation in human inherited T-bet deficiency.

Authors:  Marc Weisshaar; Federico Mele; Ibtihal Benhsaien; Karim Dorgham; Jing Han; Aziz Bousfiha; Laurent Abel; Stuart G Tangye; Jean-Laurent Casanova; Jacinta Bustamante; Federica Sallusto; Rui Yang; Carys A Croft; Samuele Notarbartolo; Jérémie Rosain; Paul Bastard; Anne Puel; Bernhard Fleckenstein; Laurie H Glimcher; James P Di Santo; Cindy S Ma; Guy Gorochov
Journal:  J Exp Med       Date:  2021-06-23       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.